Molina Healthcare, Inc. Insider Trading Activity

Accepted by SEC EDGAR 08/06/2025 - 04:47 PM EDT Learn about SEC filing dates

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 2 txns

Insider WOYS JAMES

Role Chief Operating Officer

Bought 10,000 shs ($1.56M)

Increase in Position 15.5%

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,500	$155.59	$856K
Purchase	Common Stock	4,500	$156.36	$704K

Holdings After Transaction: Common Stock — 74,331 shares (Direct)

Holdings Before and After: Common Stock, 64,331 to 74,331 shares (Direct)

Footnotes (3)

1. F1. Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $155.00 to $155.98. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.
2. F2. Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $156.01 to $156.94. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.
3. F3. The shares vest as follows: 5,337 shares on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOYS JAMES

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		P		5,500	A	$155.59(1)	69,831	D
Common Stock	08/04/2025		P		4,500	A	$156.36(2)	74,331(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $155.00 to $155.98. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

2. Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $156.01 to $156.94. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

3. The shares vest as follows: 5,337 shares on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

Remarks:

	Jeff D. Barlow, by power of attorney for James Woys	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.